A detailed history of Sicart Associates LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sicart Associates LLC holds 110,130 shares of GILD stock, worth $10.3 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares
110,130
Previous 110,130 -0.0%
Holding current value
$10.3 Million
Previous $7.56 Million 22.17%
% of portfolio
3.4%
Previous 3.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$63.15 - $72.88 $116,196 - $134,099
-1,840 Reduced 1.64%
110,130 $7.56 Million
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $120,970 - $147,520
-1,690 Reduced 1.49%
111,970 $8.2 Million
Q4 2023

Jan 19, 2024

SELL
$73.27 - $83.09 $110,271 - $125,050
-1,505 Reduced 1.31%
113,660 $9.21 Million
Q3 2023

Oct 25, 2023

SELL
$73.94 - $80.67 $12,939 - $14,117
-175 Reduced 0.15%
115,165 $8.63 Million
Q2 2023

Jul 28, 2023

SELL
$76.01 - $86.7 $479,243 - $546,643
-6,305 Reduced 5.18%
115,340 $8.89 Million
Q1 2023

May 09, 2023

SELL
$77.31 - $88.08 $1.69 Million - $1.92 Million
-21,850 Reduced 15.23%
121,645 $10.1 Million
Q4 2022

Jan 27, 2023

SELL
$62.32 - $89.47 $115,603 - $165,966
-1,855 Reduced 1.28%
143,495 $0
Q3 2022

Nov 01, 2022

SELL
$59.54 - $68.01 $1.46 Million - $1.67 Million
-24,550 Reduced 14.45%
145,350 $8.97 Million
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $45,310 - $51,032
-785 Reduced 0.46%
169,900 $10.5 Million
Q1 2022

May 06, 2022

SELL
$57.92 - $72.58 $895,153 - $1.12 Million
-15,455 Reduced 8.3%
170,685 $10.1 Million
Q4 2021

Jan 31, 2022

SELL
$64.88 - $73.64 $24,654 - $27,983
-380 Reduced 0.2%
186,140 $13.7 Million
Q3 2021

Oct 22, 2021

SELL
$67.69 - $73.03 $468,414 - $505,367
-6,920 Reduced 3.58%
186,520 $13 Million
Q2 2021

Jul 23, 2021

SELL
$63.47 - $69.35 $86,319 - $94,315
-1,360 Reduced 0.7%
193,440 $13.3 Million
Q1 2021

May 10, 2021

BUY
$60.0 - $68.46 $174,000 - $198,533
2,900 Added 1.51%
194,800 $12.6 Million
Q4 2020

Jan 22, 2021

BUY
$56.65 - $64.55 $7.44 Million - $8.48 Million
131,410 Added 217.24%
191,900 $11.2 Million
Q3 2020

Oct 14, 2020

BUY
$62.1 - $78.08 $3.76 Million - $4.72 Million
60,490 New
60,490 $3.82 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.